Currently out of the existing stock ratings of Sarah James, 112 are a HOLD (26.79%), 292 are a BUY (69.86%), 14 are a SELL (3.35%).

Sarah James

Work Performance Price Targets & Ratings Chart

Analyst Sarah James, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 64.17% that have a potential upside of 25.84% achieved within 302 days.

Sarah James’s has documented 901 price targets and ratings displayed on 34 stocks. The coverage is on Healthcare, Industrials sectors.

Most recent stock forecast was given on HCAT, Health Catalyst at 11-May-2026.

Wall Street Analyst Sarah James

Analyst best performing recommendations are on CYH (COMMUNITY HEALTH SYSTEMS).
The best stock recommendation documented was for LFMD (LIFEMD) at 3/12/2024. The price target of $11 was fulfilled within 8 days with a profit of $2.62 (31.26%) receiving and performance score of 39.08.

Average potential price target upside

of $74.51 (22.25%) on UNH (UNITEDHEALTH GROUP).
of $67.62 (20.74%) on ELV (ELEVANCE HEALTH).
of $54.31 (18.77%) on HUM (HUMANA).

CNC Centene Corp CVS CVS Health Corp CYH Community Health Systems DVA DaVita HealthCare Partners HCA HCA Holdings HUM Humana MOH Molina Healthcare OSH Oak Street Health PGNY Progyny UHS Universal Health Services UNH UnitedHealth Group CI Cigna Corp THC Tenet Healthcare WCG WellCare Health Plans ACHC Acadia Healthcare Company ALHC Alignment Healthcare LLC AMED Amedisys ANTM Anthem HSIC Henry Schein INNV InnovAge Holding Corp AMEH Apollo Medical Holdings DCGO DocGo SGRY Surgery Partners AVAH Aveanna Healthcare Holdings EHC Encompass Health Corp ELV Elevance Health PDCO Patterson Companies ACAD ACADIA Pharmaceuticals LFMD LifeMD HCAT Health Catalyst RCM R1 RCM TDOC Teladoc AME Ametek OS OneStream, Common Stock

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

John Stansel (JPMORGAN)